Serina Therapeutics Inc (SER) Stock Analysis

Serina Therapeutics Inc (SER) is a publicly traded company in the HEALTHCARE sector. It trades at $1.77, carries a market capitalization of $27.15M. This page summarizes the public market data, fundamentals, and frequently asked questions for SER, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $1.77
• Market Cap: $27.15M
• EPS: $-2.00
• 52-Week High: $7.92
• 52-Week Low: $1.22

Market Sentiment

Serina Therapeutics Inc currently has a Bullish sentiment score of 0.30.

About Serina Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Serina Therapeutics Inc (SER) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SER.

Frequently Asked Questions

Does SER pay dividends?

Serina Therapeutics Inc (SER) does not currently pay a regular dividend.

What is SER's market cap?

Serina Therapeutics Inc (SER) has a market capitalization of $27.15M with a current stock price of $1.77.